HiScreen™ column with MabSelect™ VH3 protein A resin
HiScreen™ MabSelect™ VH3 column
Prepacked column with MabSelect™ VH3 resin for efficient separation of bispecific antibodies, Fab, scFv, and VHH that contain the VH3 sequence family.
Chromatography technique | Antibody affinity chromatography |
Bed dimensions | 7.7 × 100 mm |
Bed height | 100 mm |
Bed volume | 4.7 mL |
Column i.d. | 7 mm |
Dynamic binding capacity, QB10 | ~ 70 mg mAb/mL resin at 6 min residence time ~ 60 mg mAb /mL resin at 4 min residence time |
Flow velocity | < 300 cm/h |
Pressure max. (over the packed bed during operation) | 3 bar (0.3 MPa, 44 psi) |
产品详情
Prepacked column with MabSelect™ VH3 resin. This protein A ligand interacts only with the variable heavy chain of the VH3 sequence family of the human antibody for efficient separation of bispecific antibodies (bsAb) and fragments, such as fragment antigen-binding region (Fab), single-chain variable fragment (scFv), and variable heavy domain of heavy chain (VHH).
- High binding capacity for bispecific antibodies and antibody fragments containing the VH3 sequence family.
- Provides good resolution for product-related impurities in the capture of bispecific antibodies.
- Excellent alkaline stability; stable when cleaned with 0.5 M NaOH, minimizing risk for bioburden incidents and providing a long resin lifetime.
- A single interaction with the Fab VH3 region is beneficial over a dual-interaction affinity ligand, as separation of unwanted mispaired antibodies and fragments from target bsAb may be more efficient.
- Easily measure protein A leakage using the VH3 ligand ELISA kit specifically designed for use with MabSelect™ VH3 resin.
MabSelect™ VH3 chromatography resin in different formats
To support process development, manufacturing, and research, MabSelect™ VH3 resin is available in 25 mL, 200 mL, 1 L, 5 L, and 10 L containers. The resin can also be ordered in prepacked formats such as HiTrap™ columns, HiScreen™ columns, PreDictor™ plates, and ReadyToProcess™ columns. Contact us to learn more.